CHEP+ Clinical Practice Guidelines Program

CV Risk Reduction in Diabetes (SGLT2 inhibitors/GLP-1 Receptor Agonists in Patients with DM and CVD)

Thursday, February 4th, 2021 • 7 PM - 9 PM (ET)

Presented By: Jeff Habert, MD, CCFP, FCFP

Dr. Habert is an Assistant Professor in the Department of Family and Community Medicine at the University of Toronto, Co-Chair of the Clinical Practice Guidelines Committee Thrombosis Canada.

LEARNING OBJECTIVES

Upon completion of this case study, participants should be able to:

• Describe the patient who should be treated with an SGLT2i or GLP-1 RA
• Explain the rationale for this treatment and the potential benefits
• Describe the steps for initiating and monitoring therapy for patients with diabetes

Accreditation: This Group Learning program has been certified by the Canadian College of Family Physicians for up to 6 Mainpro+ credits for the 2-hour presentation including a practice reflection survey to be completed at 6 weeks post-session.

You will receive an email before the event with the details on how to join Online.

FAQs

• How can I contact the organizer with any questions? To contact the organizer, email: Diane Hua-Stewart at Diane.Hua@sunnybrook.ca / (416) 710-3892.

• To learn more: Please visit www.chepplus.com